Centrient Pharmaceuticals
Astrid Bierman is a seasoned professional in Regulatory Affairs and Marketing within the pharmaceuticals sector, currently serving as a Regulatory Affairs Planner and Coordinator at Centrient Pharmaceuticals since April 2018. Before this role, Astrid held various positions, including Marketing & Sales Assistant at Mylan and Sales & Marketing Assistant at Meda, where support for product management and marketing events was crucial. Notable earlier roles include Project Manager and Product Launch Supervisor at Apotex Nederland BV, focusing on operational activities and new product launches. Astrid's extensive educational background includes certifications in project management and corporate governance, with a strong foundation in pharmacy. This diverse experience reflects a robust expertise in regulatory processes, project coordination, and marketing, contributing significantly to cross-functional operations in international settings.
This person is not in any teams
This person is not in any offices
Centrient Pharmaceuticals
2 followers
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs). We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 1,800 employees work continuously to meet our customers’ needs. We work towards a sustainable future by actively participating in the fight against antimicrobial resistance. Founded 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, our company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rotterdam (Netherlands), we have production facilities and sales offices in China, India, the Netherlands, Spain, the United States and Mexico. Centrient Pharmaceuticals is owned by Bain Capital Private Equity, a leading global private investment firm.